They are so supportive, efficient and reactive
In participants without diabetes, treatment with the 7.2 mg dose resulted in an average weight loss of nearly 19%, outperforming the 16% reduction seen with 2.4 mg and the 4% seen with placebo
Changchien L, Dusza SW, Agero AL, et al
Our experienced medical team will work with you to determine if semaglutide is appropriate for your health profile and weight loss goals
We are encouraged by both the safety profile and initial efficacy, in which MET-097 achieved weight loss matching, or potentially exceeding, currently available and investigational next-generation GLP-1 and GLP-1 combination drugs
With features like virtual consultations, ongoing support, and digital tools for tracking progress, many find it a practical solution that fits into busy lifestyles